Metraipolis › archive › dc_33bd61787147

Molecular guided therapy leading to exceptional response in relapsed osteosarcoma — Europe PMC PMID:41560724

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41560724
DOI
10.3389/fphar.2025.1719832
License (as archived)
solo-consultazione
Archived
2026-11-07T01:38:57.442Z
SHA-256 of the archived text
35a48db755dba6a03d249cf911c1f8fe6bef9c00175943acc6803354196cf7f9
Stable URL of this page
https://metraipolis.com/documento/dc_33bd61787147

How to cite

Molecular guided therapy leading to exceptional response in relapsed osteosarcoma — Europe PMC PMID:41560724 — Europe PMC (en), https://europepmc.org/article/MED/41560724 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33bd61787147 (Metraipolis archive dc_33bd61787147, sha256 35a48db755dba6a03d249cf911c1f8fe6bef9c00175943acc6803354196cf7f9)
BibTeX
@misc{dc33bd61787147,
  title = {Molecular guided therapy leading to exceptional response in relapsed osteosarcoma — Europe PMC PMID:41560724},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41560724},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33bd61787147; sha256 35a48db755dba6a03d249cf911c1f8fe6bef9c00175943acc6803354196cf7f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41560724. Agents can read the archived copy with the MCP tool read_document.